研報掘金丨長江證券:寶信軟件經營拐點仍需等待,建議持續關注
長江證券研報指出,寶信軟件(600845.SH)2024年歸母淨利潤22.65億元,同比下降11.28%;Q4實現歸母淨利潤3.35億元,同比下降50.89%。Q4營收延續下滑,經營拐點仍需等待。整體而言,短期行業承壓、集團動作收縮等因素影響下公司收入兑現或有延後,長期仍看好中大型PLC寶武體系內推廣的潛力與確定性,有待持續跟蹤。公司大力發展AI+機器人,IDC或開啟新一輪建設週期。一方面公司積極響應集團戰略,推動AI驅動鋼鐵行業智能化轉型升級,逐步探索形成鋼鐵行業垂類大模型產業生態。年報顯示2024年在建工程同比增長47%,顯示寶之雲華北基地建設正常推進,IDC業務或將進入新一輪擴產週期。建議持續關注。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.